Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2006

Open Access 01.12.2006 | Case report

Oncocytic carcinoma of parotid gland: a case report with clinical, immunohistochemical and ultrastructural features

verfasst von: Giovanna Giordano, Marzio Gabrielli, Letizia Gnetti, Teore Ferri

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2006

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Oncocytic carcinoma is an extremely rare neoplasm of the salivary glands. We report a case of oncocytic carcinoma arising in a parotid gland in a 66-year-old female.

Method

An excisional biopsy of the parotid tumor was performed. The specimen was submitted for histology and after fixation in formalin solution and inclusion in paraffin, 3–5 μm sections were stained with hematoxylin and eosin for conventional evaluation and Periodic acid Schiff stain. Immunohistochemical studies were performed using antibodies against mitochondrial antigen, keratin, S-100, alpha-actin, vimentin, alpha-1-antichymotrypsin as well as an ultrastructural analysis was performed.

Results

Frozen sections revealed an infiltrative growth pattern and the diagnosis of a malignant epithelial lesion was made. Permanent sections stained with haematoxylin and eosin revealed a neoplasm that had replaced a wide area of the parotid gland and had invaded subcutaneous adipose tissue. Perineural invasion was evident, but vascular invasion was not found. Neoplastic elements were large, round or polyhedral cells and were arranged in solid sheets, islands and cords. The cytoplasm was abundant, eosinophilic and finely granular. The nuclei were large and located centrally or peripherally. The nucleoli were distinct and large. Periodic acid Schiff stain demonstrated a granular cytoplasm. Immunohistochemistry demonstrated mithochondrial antigen, keratin, and chymotrypsin immunoreactivity in the neoplastic cells. Ultrastructural analysis revealed numerous mitochondria packed into the cytoplasm of the neoplastic cells. Thus, the final diagnosis was that of oncocytic carcinoma of parotid gland.

Conclusion

This neoplasm shows clinical, microscopical, histological and ultrastructural features of oncocytic carcinoma and this must be considered in the differential diagnosis of other proliferations in the parotid gland with abundant granular cytoplasm and metastatic oncocytic carcinomas.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1477-7819-4-54) contains supplementary material, which is available to authorized users.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

GG: Wrote the manuscript and did the pathological work-up
MG: Did the pathological work-up and prepared photomicrographs
LG: reviewed the literature and helped in preparation of manuscript
TF: operated on the patient and revised the manuscript

Background

The occurrence of oncocytic carcinoma of the parotid gland is rare. A new case of oncocytic carcinoma in a parotid gland has been reported recently by Guclu et al [1]. According to a review of the literature performed by these authors, only 41 cases have been reported [1]. We report a case of oncocytic carcinoma of the parotid gland with its clinical manifestations and pathological features.

Case presentation

A 66-year-old female was admitted to our Institution with a history of a painless left preauricular nodule that had gradually increased in size. Computed tomographic (CT) scan revealed a 2 × 2.5 cm solid lesion in the left parotid gland. Cervical and peri-aortic lymph nodes were not enlarged, except for one in the submandibular region.
Total parotidectomy with preservation of the facial nerve was performed. Thus, the parotid gland and covering skin were removed. Lateral jugular lymph nodes dissection was carried out.
The lesion was initially examined in frozen sections. The specimen was submitted for histology and after fixation in formalin solution and inclusion in paraffin, 3–5 μm sections were stained with haematoxylin and eosin for conventional evaluation and a Periodic acid Schiff stain also carried out. A panel of immunostains, including antibodies against mitochondrial antigen, keratin (Citok AE1, Citok AE3), carcinoembryonal antigen (CEA), vimentin, alpha-1-antichymotrypsin, smooth muscle actin and S-100, was applied to representative sections of the tumour using the avidin-biotin complex technique (Table 1). Formalin-fixed small fragments of neoplasm were also examined by electron microscopy, after washing in 0,1 M phosphate buffer, postfixation in osmium tetroxide, dehydratation in ethanol and embedding in epon-araldite.
Table 1
Primary antibodies used for immunophenotyping
Antibody
Manufacturer
Dilution
Method
Mitochondrial antigen
BioGenex
1:500
ABC
Citok AE1/AE3
Dako
1:100
ABC
CEA
Dako
1: 25
ABC
Vimentin
Neomarkers
1:500
ABC
Alpha-1-anticymotrypsin
Dako
1: 800
ABC
Smooth muscle actin
Neomarkers
1:500
ABC
S100 protein
BioGenex
1:500
ABC
Ultrathin sections were stained with uranyl acetate and lead citrate and examined with a Philips EM 208 electronic microscope.

Results

Macroscopically, the tumour was a well-circumscribed, firm, grey-brown, ovoid nodule measuring 2.5 cm in diameter. Imprint cytology of the lesion showed cohesive clusters of neoplastic cells. The cytoplasm was abundant and finely granular. The nuclei were moderately pleomorphic, medium or large and were located centrally or peripherally (Figure 1a). Frozen section revealed an infiltrative growth pattern and the diagnosis of a malignant epithelial lesion was made.
Permanent sections stained with haematoxylin and eosin revealed that the neoplasm that had replaced a wide area of the parotid gland and had invaded subcutaneous adipose tissue (figure 1b). Perineural invasion was evident (figure 1c), but vascular invasion was not found. Neoplastic elements were large, round or polyhedral cells and were arranged in solid sheets, islands and cords. The cytoplasm was abundant, eosinophilic and finely granular. The nuclei were large and located centrally or peripherally. The nucleoli were distinct and large (figure 1d). Periodic acid Schiff stain demonstrated a granular cytoplasm.
Immunohistochemically, the tumour strongly reacted with mithochondrial antigen (Figure 2a), keratin (Figure 2b), alpha-1-antichymotrypsin (Figure 2c and 2d), but was negative for smooth muscle actin, vimentin and carcinoembryonal antigen (CEA) and S-100 protein (S-100). All lymph nodes examined were negative for metastases.
On ultrastructural examination, the cytoplasm of neoplastic cells seemed to be packed with numerous mitochondria. These organuli were not clear, since their cristae appeared fragmented because of fixation in formalin solution without adjusted pH.

Discussion

Oncocytic carcinoma is an extremely rare malignancy in salivary glands, accounting only for 11% of all oncocytic salivary gland neoplasms, 0.5% of all epithelial salivary gland malignancies and 0.18% of all epithelial salivary gland tumours [2]. This neoplasm is characterized by epithelial cells with abundant eosinophilic and granular cytoplasm, filled with numerous mitochondria.
Malignant oncocytoma, malignant oxyphilic adenoma and oncocytic adenocarcinoma have been used synonymously for oncocytic carcinoma. The malignant nature of the neoplasm can be recognized by its morphologic features and infiltrative growth. Morphologic criteria for the diagnosis of a malignant nature are cellular pleomorphism, necrosis and frequent mitoses. Infiltrative growth of the neoplasm is represented by perineural, vascular or lymphatic invasion, destruction of adjacent structures and local lymph node metastasis.
Immunohistochemical study and ultrastructural examination are essential ancillary studies necessary for a correct diagnosis of oncocytic carcinoma to be made; these procedures show the presence of abundant mitochondria in cytoplasm.
In our case, the malignant nature of the neoplasm was evidenced by the presence of perineural invasion and by infiltration of subcutaneous tissue. No regional or distant lymph node metastases clinically or radiologically were observed.
Oncocytic differentiation of neoplastic cells was demonstrated by immunohistochemical positivity for mithochondrial antigen [3], keratin, alpha-1-antichymotrypsin [4]. On ultrastructural analysis numerous mitochondria seemed to fill the cytoplasm. These organuli were not clear because of fixation of tissue for light microscopy, which is similar to the case reported by Mizutary et al [5]. Other neoplasms that arise from the salivary gland with a granular cytoplasm are oncocytoma, acinic cell adenocarcinoma and salivary duct carcinoma [6].
Oncocytic carcinoma can be differentiated from benign oncocytoma by the presence of a connective tissue capsule in the latter. Moreover, compared to oncocytoma, oncocytic carcinoma usually shows a greater mitotic activity and more nuclear pleomorphism.
Acinic cell adenocarcinoma can be differentiated from oncocytic carcinoma since its cytoplasmic granules are amphophilic or basophilic. Moreover, the patterns of growth in acinic cell adenocarcinoma can be microcystic or papillary and the neoplastic elements are negative for mithochondrial antigen when examined immunohistochemically. Salivary duct carcinoma, in contrast to oncocytic carcinoma, forms duct-like spaces with papillary and cribriform growth and also shows comedonecrosis [6].
The non-neoplastic proliferation of a salivary gland, which can mimic oncocytic carcinoma is oncocytosis. This lesion is a condition that predominantly affects adults over the age of 60 years, and can be differentiated from malignant oncocytoma by the presence of variably sized foci of oncocytic cells within glandular lobules without altering the normal architecture of the gland [6].
Primary oncocytic carcinoma of the salivary glands should also be differentiated from metastatic oncocytic carcinomas to the salivary glands from a precise clinical history, revealing the previous primary neoplasm and by specific immunohistochemical studies.
Metastatic oncocytic carcinoma of the thyroid (Hürthle cell carcinoma) can be diagnosed because of the immunohistochemical expression of thyroglobulin [7].
The diagnosis of a rare metastatic oncocytic adenocarcinoma of the stomach to the salivary gland is facilitated by the presence of a tubular pattern of growth and by the presence of microvilli on the luminal surfaces of neoplastic cells, which are absent in salivary oncocytic carcinoma of the salivary gland [8].
Metastatic renal cell carcinoma, the granular type, must be considered in the differential diagnosis of primary oncocytic carcinoma in a salivary gland. This variant of renal carcinoma is characteristically composed of cells organized in sheets, cords or as papillary fronds [9]. On immunohistochemical examination, oncocytic carcinoma in a salivary gland is negative for carcinoembryonal antigen (CEA) and S-100 protein [10] in contrast with renal carcinoma [11, 12] which is positive to either markers. In our case, the diagnosis of primary oncocytic carcinoma of parotid gland was made by immunohistochemical analysis revealing negativity for S100 and CEA according to other studies reported in the literature [10] and by a negative clinical history for a renal tumour.
The prognosis of oncocytic carcinoma in salivary gland is not well known, because of its rarity. Goode and Corio have reported that tumours smaller than 2 cm in diameter appeared to have a better prognosis than those that were larger [13].
In our case, the neoplasm was 2.5 cm in diameter and was not associated with local or distant metastases. A good prognosis is expected for our patient, because there was not involvement of the lymph nodes.

Conclusion

Oncocytic oncocytic carcinoma may have similar morphologic features with other neoplasms. However histological, immunohistological and ultrastructural features will aid in differentiating one from the other.

Acknowledgements

Written permission was obtained from the patient for publication of this case report. The Authors wish to express their gratitude to Mrs Emilia Corradini and Mrs Gabriella Becchi for technical assistance.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

GG: Wrote the manuscript and did the pathological work-up
MG: Did the pathological work-up and prepared photomicrographs
LG: reviewed the literature and helped in preparation of manuscript
TF: operated on the patient and revised the manuscript
Anhänge

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.
Literatur
1.
Zurück zum Zitat Guclu E, Oghan F, Ozturk O, Alper M, Egeli E: A rare malignancy of the parotid gland: oncocytic carcinoma. Eur Arch Otorhinolaryngol. 2005, 262: 567-569. 10.1007/s00405-004-0871-4.CrossRefPubMed Guclu E, Oghan F, Ozturk O, Alper M, Egeli E: A rare malignancy of the parotid gland: oncocytic carcinoma. Eur Arch Otorhinolaryngol. 2005, 262: 567-569. 10.1007/s00405-004-0871-4.CrossRefPubMed
2.
Zurück zum Zitat Ellis GL, Auclair PL, Gnepp DR, Goode RK: Other malignant epithelial neoplasms. Surgical pathology of the salivary glands. 1991, Saunders W Philadelphia, 455-488. Ellis GL, Auclair PL, Gnepp DR, Goode RK: Other malignant epithelial neoplasms. Surgical pathology of the salivary glands. 1991, Saunders W Philadelphia, 455-488.
3.
Zurück zum Zitat Shintaku M, Honda T: Identification of oncocytic lesions of salivary glands by anti-mitochondrial immunohistochemistry. Histopathology. 1997, 31: 408-411. 10.1046/j.1365-2559.1997.2870891.x.CrossRefPubMed Shintaku M, Honda T: Identification of oncocytic lesions of salivary glands by anti-mitochondrial immunohistochemistry. Histopathology. 1997, 31: 408-411. 10.1046/j.1365-2559.1997.2870891.x.CrossRefPubMed
4.
Zurück zum Zitat Muramatsu T, Hashimoto S, Lee MW, Chung CK, Matsuzaki K, Inoue T, Noma H, Shimono M: Oncocytic carcinoma arising in submandibular gland with immunohistochemical observations and review of the literature. Oral Oncol. 2003, 39: 199-203. 10.1016/S1368-8375(02)00031-3.CrossRefPubMed Muramatsu T, Hashimoto S, Lee MW, Chung CK, Matsuzaki K, Inoue T, Noma H, Shimono M: Oncocytic carcinoma arising in submandibular gland with immunohistochemical observations and review of the literature. Oral Oncol. 2003, 39: 199-203. 10.1016/S1368-8375(02)00031-3.CrossRefPubMed
5.
Zurück zum Zitat Mazutari K, Naganishi h, Tanaka Y: Oncocytic carcinoma in the submandibular gland of a case based on anti-mitochondrial immunohistochemical observation. Auris Nasus Larynx. 2005, 32: 305-308. 10.1016/j.anl.2005.03.006.CrossRef Mazutari K, Naganishi h, Tanaka Y: Oncocytic carcinoma in the submandibular gland of a case based on anti-mitochondrial immunohistochemical observation. Auris Nasus Larynx. 2005, 32: 305-308. 10.1016/j.anl.2005.03.006.CrossRef
6.
Zurück zum Zitat Ellis GL, Auclair PL: Oncocytic carcinoma. Atlas Tumour Pathology. Tumour of salivary glands 3rd series, fascicle 17. 1996, Armed Forces Institute of Pathology. Washington DC, 318-324. Ellis GL, Auclair PL: Oncocytic carcinoma. Atlas Tumour Pathology. Tumour of salivary glands 3rd series, fascicle 17. 1996, Armed Forces Institute of Pathology. Washington DC, 318-324.
7.
Zurück zum Zitat Johnson TL, Lloyd RV, Burney ER, Thompson NW: Hürthle cell thyroid tumours. An immunohistochemical study. Cancer. 1987, 59: 107-12. 10.1002/1097-0142(19870101)59:1<107::AID-CNCR2820590123>3.0.CO;2-U.CrossRefPubMed Johnson TL, Lloyd RV, Burney ER, Thompson NW: Hürthle cell thyroid tumours. An immunohistochemical study. Cancer. 1987, 59: 107-12. 10.1002/1097-0142(19870101)59:1<107::AID-CNCR2820590123>3.0.CO;2-U.CrossRefPubMed
8.
Zurück zum Zitat Takubo K, Honma N, Sawabe M, Arai T, Izumiyama-Shimomura N, Kammori M, Sasajima K, Esaki Y: Oncocytic adenocarcinoma of the stomach. Am J Surg Pathol. 2002, 26: 458-465. 10.1097/00000478-200204000-00007.CrossRefPubMed Takubo K, Honma N, Sawabe M, Arai T, Izumiyama-Shimomura N, Kammori M, Sasajima K, Esaki Y: Oncocytic adenocarcinoma of the stomach. Am J Surg Pathol. 2002, 26: 458-465. 10.1097/00000478-200204000-00007.CrossRefPubMed
9.
Zurück zum Zitat Murphy WL, Bruce Beckwith J, Farrow GM: Tumours of the kidney. Atlas Tumour Pathology. Tumour of the kidney, bladder, and related urinary structures 3rd series, fascicle 11. 1994, Armed Forces Institute of Pathology, Washington DC, 110-112. Murphy WL, Bruce Beckwith J, Farrow GM: Tumours of the kidney. Atlas Tumour Pathology. Tumour of the kidney, bladder, and related urinary structures 3rd series, fascicle 11. 1994, Armed Forces Institute of Pathology, Washington DC, 110-112.
10.
Zurück zum Zitat Alberty J, August C, Stoll W: Oncocytic neoplasms of the parotid gland. Differential diagnosis, clinical course and review of the literature. HNO. 2001, 49: 109-17. 10.1007/s001060050719.CrossRefPubMed Alberty J, August C, Stoll W: Oncocytic neoplasms of the parotid gland. Differential diagnosis, clinical course and review of the literature. HNO. 2001, 49: 109-17. 10.1007/s001060050719.CrossRefPubMed
11.
Zurück zum Zitat Ghazizadeh M, Kagawa S, Kurokawa K: Immunohistochemical studies of human renal cell carcinomas for ABO(H) blood group antigens, T antigen-like substance and carcinoembryonic antigen. J Urol. 1985, 133: 762-766.PubMed Ghazizadeh M, Kagawa S, Kurokawa K: Immunohistochemical studies of human renal cell carcinomas for ABO(H) blood group antigens, T antigen-like substance and carcinoembryonic antigen. J Urol. 1985, 133: 762-766.PubMed
12.
Zurück zum Zitat Takashi M, Haimoto H, Murase T, Mitsuya H, Kato K: An immunochemical and immunohistochemical study of S100 protein in renal cell carcinoma. Cancer. 1988, 61: 889-895. 10.1002/1097-0142(19880301)61:5<889::AID-CNCR2820610506>3.0.CO;2-7.CrossRefPubMed Takashi M, Haimoto H, Murase T, Mitsuya H, Kato K: An immunochemical and immunohistochemical study of S100 protein in renal cell carcinoma. Cancer. 1988, 61: 889-895. 10.1002/1097-0142(19880301)61:5<889::AID-CNCR2820610506>3.0.CO;2-7.CrossRefPubMed
13.
Zurück zum Zitat Goode RK, Corio RL: Oncocytic adenocarcinoma of salivary glands. Oral Surg Oral Med Oral Pathol. 1988, 65: 61-66. 10.1016/0030-4220(88)90193-4.CrossRefPubMed Goode RK, Corio RL: Oncocytic adenocarcinoma of salivary glands. Oral Surg Oral Med Oral Pathol. 1988, 65: 61-66. 10.1016/0030-4220(88)90193-4.CrossRefPubMed
Metadaten
Titel
Oncocytic carcinoma of parotid gland: a case report with clinical, immunohistochemical and ultrastructural features
verfasst von
Giovanna Giordano
Marzio Gabrielli
Letizia Gnetti
Teore Ferri
Publikationsdatum
01.12.2006
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2006
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-4-54

Weitere Artikel der Ausgabe 1/2006

World Journal of Surgical Oncology 1/2006 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.